NVP-BSK805
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 406124

CAS#: 1092499-93-8

Description: NVP-BSK805 is a JAK2 inhibor, which displays more than 20-fold selectivity towards JAK2 in vitro, as well as excellent selectivity in broader kinase profiling. In vivo, NVP-BSK805 exhibited good oral bioavailability and a long half-life. The inhibitor was efficacious in suppressing leukemic cell spreading and splenomegaly in a Ba/F3 JAK2(V617F) cell-driven mouse mechanistic model. Furthermore, NVP-BSK805 potently suppressed recombinant human erythropoietin-induced polycythemia and extramedullary erythropoiesis in mice and rats.


Price and Availability

Size
Price

10mg
USD 190
100mg
USD 850
1g
USD 3250
Size
Price

25mg
USD 350
200mg
USD 1250
2g
USD 4650
Size
Price

50mg
USD 550
500mg
USD 2150
5g
Ask price

NVP-BSK805, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 406124
Name: NVP-BSK805
CAS#: 1092499-93-8
Chemical Formula: C27H28F2N6O
Exact Mass: 490.22927
Molecular Weight: 490.55
Elemental Analysis: C, 66.11; H, 5.75; F, 7.75; N, 17.13; O, 3.26


Synonym: NVPBSK805; NVP-BSK805; BSK805; BSK 805

IUPAC/Chemical Name: 8-(3,5-difluoro-4-(morpholinomethyl)phenyl)-2-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxaline

InChi Key: IBPVXAOOVUAOKJ-UHFFFAOYSA-N

InChi Code: InChI=1S/C27H28F2N6O/c28-23-12-18(13-24(29)22(23)17-34-8-10-36-11-9-34)21-2-1-3-25-27(21)33-26(15-31-25)19-14-32-35(16-19)20-4-6-30-7-5-20/h1-3,12-16,20,30H,4-11,17H2

SMILES Code: FC1=C(CN2CCOCC2)C(F)=CC(C3=C4N=C(C5=CN(C6CCNCC6)N=C5)C=NC4=CC=C3)=C1


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>5 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


Additional Information

  
 
 
 


References

1: Rubert J, Qian Z, Andraos R, Guthy DA, Radimerski T. Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival. BMC Cancer. 2011 Jan 19;11:24. doi:  10.1186/1471-2407-11-24. PubMed PMID: 21247487; PubMed Central PMCID: PMC3037340.

2: Baffert F, Régnier CH, De Pover A, Pissot-Soldermann C, Tavares GA, Blasco F,  Brueggen J, Chène P, Drueckes P, Erdmann D, Furet P, Gerspacher M, Lang M, Ledieu D, Nolan L, Ruetz S, Trappe J, Vangrevelinghe E, Wartmann M, Wyder L, Hofmann F,  Radimerski T. Potent and selective inhibition of polycythemia by the quinoxaline  JAK2 inhibitor NVP-BSK805. Mol Cancer Ther. 2010 Jul;9(7):1945-55. doi: 10.1158/1535-7163.MCT-10-0053. Epub 2010 Jun 29. PubMed PMID: 20587663.